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Abstract
Following a request from the European Commission, the EFSA Panel on Additives and Products or
Substances used in Animal Feed (FEEDAP) was asked to deliver a scientiﬁc opinion on the safety and
efﬁcacy of Levucell® SB when used in feed for turkeys for fattening. The additive is intended for use as a
zootechnical additive (functional group: other additives) for the reduction of Salmonella contamination
on carcasses through its decrease in faeces. In the context of a previous opinion, the identity of the strain
was conﬁrmed, and according to the Qualiﬁed Presumption of Safety (QPS) approach to safety
assessment, it was presumed safe for the target species, consumers and the environment. Since no
concerns are expected from other components of the additive, Levucell® SB is also considered safe for
the target species, consumers and the environment. The additive is not a skin or eye irritant or a skin
sensitiser. Considering the data on the dusting potential, the user can be exposed to the additive by
inhalation when handling it. The additive in non-encapsulated form should be considered as a respiratory
sensitiser. The coated formulation is not considered to pose a risk by inhalation. The efﬁcacy of Levucell®
SB for the same purpose was previously established in chickens for fattening. The FEEDAP
Panel concluded that there was some evidence that the addition of Levucell® SB at 2 9 1010 CFU/kg
feed has a potential to aid the reduction of carcass contamination with Salmonella spp. Since the
mechanism of action of the additive can be reasonably assumed to be same, Levucell® SB can be
presumed efﬁcacious in turkeys for fattening at a dose of 2 9 1010 CFU/kg feed without the need for
additional studies.
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1. Introduction
1.1. Background and Terms of Reference
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of
additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any person
seeking authorisation for a feed additive or for a new use of a feed additive shall submit an application in
accordance with Article 7.
The European Commission received a request from Danstar Ferment AG2 for authorisation of the
product Levucell® SB (Saccharomyces cerevisiae CNCM I-1079), when used as a feed additive for turkeys
for fattening (category: zootechnical additives; functional group: other zootechnical additives – reduction
of carcass contamination with Salmonella spp.).
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the application
to the European Food Safety Authority (EFSA) as an application under Article 4(1) (authorisation of a feed
additive or new use of a feed additive). The particulars and documents in support of the application were
considered valid by EFSA as of 25 November 2018.
According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and
documents submitted by the applicant, shall undertake an assessment in order to determine whether the
feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the
safety for the target animals, consumer, user and the environment and on the efﬁcacy of the product
Levucell® SB (Saccharomyces cerevisiae CNCM I-1079), when used under the proposed conditions of use
(see Section 3.1).
1.2. Additional information
The additive Levucell® SB is a preparation of S. cerevisiae (CNCM I-1079).
Levucell SB® is currently authorised for use as a zootechnical additive in sows and weaned piglets3
(gut ﬂora stabiliser) and in chickens for fattening and in minor poultry species (other zootechnical
additive).4
The EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) produced
some opinions on the safety and efﬁcacy of Levucell® SB when used as a feed additive for weaned
piglets and sows (EFSA FEEDAP Panel, 2016), chickens for fattening and minor poultry species (EFSA
FEEDAP Panel, 2017a), and all pigs (EFSA FEEDAP Panel, 2019).
2. Data and methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of a technical
dossier5 in support of the authorisation request for the use of Levucell® SB as a feed additive.
The FEEDAP Panel used the data provided by the applicant together with data from other sources,
such as previous risk assessments by EFSA, to deliver the present output.
The European Union Reference Laboratory (EURL) considered that the conclusions and
recommendations reached in the previous assessment are valid and applicable for the current application.6
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
2 Danstar Ferment AG, Switzerland represented in EU by Lallemand SAS, 19 Rue des Briquetiers, Blagnac, France.
3 Commission Implementing Regulation (EU) 2018/347 of 5 March 2018 concerning the authorisation of the preparation of
Saccharomyces cerevisiae CNCM I-1079 as a feed additive for piglets and sows and amending Regulations (EC) No 1847/2003
and (EC) No 2036/2005 (holder of authorisation Danstar Ferment AG represented by Lallemand SAS). OJ L 67. 9.3.2018, p. 21.
4 Commission Implementing Regulation (EU) 2017/1905 of 18 October 2017 concerning an authorisation of the preparation of
Saccharomyces cerevisiae CNCM I-1079 as a feed additive for chickens for fattening and for minor poultry species for fattening
(holder of authorisation Danstar Ferment AG represented by Lallemand SAS). OJ L 269. 19.10.2017, p. 30.
5 FEED dossier reference: FAD-2018-0050.
6 The full report is available on the EURL website: https://ec.europa.eu/jrc/sites/jrcsh/files/ﬁnrep-fad-2010-0121-levucell.pdf
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2.2. Methodologies
The approach followed by the FEEDAP Panel to assess the safety and the efﬁcacy of Levucell® SB
is in line with the principles laid down in Regulation (EC) No 429/20087 and the relevant guidance
documents: Guidance on the identity, characterisation and conditions of use of feed additives (EFSA
FEEDAP Panel, 2017b), Guidance on the characterisation of microorganisms used as feed additives or
as production organisms (EFSA FEEDAP Panel, 2018a), Guidance on the assessment of the safety of
feed additives for the target species (EFSA FEEDAP Panel, 2017c) and Guidance on the assessment of
the efﬁcacy of feed additives (EFSA FEEDAP Panel, 2018b).
3. Assessment
The present opinion deals with the assessment of the safety and efﬁcacy of Levucell® SB
(Saccharomyces cerevisiae CNCM I-1079) as a zootechnical feed additive (functional group: other
zootechnical additives – reduction of carcass contamination with Salmonella spp.) for turkeys for
fattening.
3.1. Characterisation of the additive and conditions of use
The additive is composed of dried cells of the active agent Saccharomyces cerevisiae CNCM I-1079.
The strain is deposited at the Collection Nationale de Cultures de Microorganismes (CNCM), France,
with the accession number CNCM I-1079.8 The strain is not been genetically modiﬁed.
The additive is marketed in two forms:
• Levucell® SB20 a ﬁne, granulated free-ﬂowing powder with a minimum concentration of
2 9 1010 colony forming units (CFU)/g,
• Levucell® SB10 ME and Levucell® SB10 ME TITAN, coated or microencapsulated forms with a
minimum concentration of 1 9 1010CFU/g.
The additive under assessment has the same composition and method of manufacture as those
considered in a previous application (EFSA FEEDAP Panel, 2016a). The applicant has provided results
on ﬁve batches for each form on batch-to-batch variation, purity, particle size and dusting potential.
The content of the active agent was from 3 to 6 (mean: 4.1) x 1010 CFU/g and from 1.7 to
2.0 9 1010 CFU/g (mean: 1.8) for the non-encapsulated and coated formulations, respectively.9
The purity of the additive was evaluated only concerning the microbial parameters. Five batches of
each formulation were tested for presence of viable yeasts, aerobic bacteria, solids, Salmonella,
Escherichia coli and Enterobacteriaceae or coliforms, moulds.9 Based on the results, no concerns were
identiﬁed.
Particle size distribution of three batches for each preparation of the product was measured by
mechanical sieving. The highest percentage of particle of a size below 45 lm was 0.3% in the non-
encapsulated product. No particle of a size below 355 lm was found in the coated product.10
The same batches analysed for particle size were also used for the evaluation of the dusting
potential by the Stauber–Heubach method. Dusting potential for the non-encapsulated product
produced an average of 0.6 g/m3 of dust, while the coated product was dust-free.11
The identity and characterisation of the active agent was described in a previous opinion (EFSA
FEEDAP Panel, 2016).
The additive is intended for use in feed for turkeys for fattening at the minimum recommended
level of 1 9 109 CFU per kg feed.
7 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC)
No 1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications
and the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1.
8 Technical dossier/Section II/Annex_II_4b.
9 Technical dossier/Section II/Annex_II_2.
10 Technical dossier/Section II/Annex_II_3b.
11 Technical dossier/Section II/Annex_II_3c.
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3.2. Safety
The species Saccharomyces cerevisiae is considered by EFSA to be suitable for the Qualiﬁed
Presumption of Safety (QPS) approach to safety assessment (EFSA, 2007; EFSA BIOHAZ Panel, 2017).
This approach requires the identity of the strain to be conclusively established.
In the context of a previous opinion (EFSA FEEDAP Panel, 2016), the identity of the strain was
conﬁrmed as S. cerevisiae. Accordingly, this strain is presumed safe for the target species, consumers of
products from animals fed the additive and the environment. Since no concerns are expected from other
components of the additive, Levucell® SB is also considered safe for the target species, consumers of
products from animals fed the additive and the environment.
EFSA evaluated the safety of Levucell® SB (non-encapsulated form) for the user in a previous
opinion and concluded that it is not a skin or eye irritant or a skin sensitiser (EFSA FEEDAP Panel,
2017a,b,c). Considering the data on dusting potential, the user can be exposed by inhalation. The
additive in non-encapsulated form should be considered as a respiratory sensitiser. The coated
formulation (Levucell® SB10 ME Titan) is not considered to pose a risk by inhalation.
The FEEDAP Panel considers that the new use requested by the applicant would not introduce
hazards/risks not already considered in previous assessments.
3.3. Efﬁcacy
The additive is intended for use in turkeys for fattening as a zootechnical additive (functional
group: other additives) for the reduction of Salmonella contamination on carcasses through its
decrease in faeces.
The efﬁcacy of Levucell® SB for the same purpose was previously established in chickens for
fattening. Based on ﬁve efﬁcacy studies in chickens for fattening the FEEDAP Panel concluded that
there is some evidence that the addition of Levucell® SB to diets has a potential to aid the reduction
of carcass contamination with Salmonella spp. and so to improve the quality of poultry products. The
effective dose appears to be 2 9 1010 CFU/kg feed (EFSA FEEDAP Panel, 2017a).
Since the mechanism of action of the additive can be reasonably assumed to be same, Levucell®
SB can be presumed efﬁcacious in turkeys for fattening at a dose of 2 9 1010 CFU/kg feed without the
need for additional studies.
3.4. Post-market monitoring
The FEEDAP Panel considers that there is no need for speciﬁc requirements for a post-market
monitoring plan other than those established in the Feed Hygiene Regulation12 and Good
Manufacturing Practice.
4. Conclusions
The additive is considered safe for turkeys for fattening, consumers of products from treated
animals and the environment.
Levucell® is not a skin or eye irritant or a skin sensitiser. The additive in non-encapsulated form
should be considered as a respiratory sensitiser. The coated formulation (Levucell® SB10 ME Titan) is
not considered to pose a risk by inhalation.
The addition of the additive to diets for turkeys for fattening at a dose of 2 9 1010 CFU/kg feed
can aid the reduction of carcass contamination with Salmonella spp..
Documentation provided to EFSA
1) Levucell SB for turkeys for fattening. July 2018. Submitted by Danstar Ferment AG,
Switzerland represented in EU by Lallemand SAS.
2) Comments from Member States.
12 Regulation (EC) No 183/2005 of the European Parliament and of the Council of 12 January 2005 laying down requirements for
feed hygiene. OJ L 35, 8.2.2005, p. 1.
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